Regulation of quiescence in lymphocytes

Trends in Immunology

Volumn 24, Issue 7, 2003, Pages 380-386

  Yusuf, Isharat ^a   Fruman, David A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ANTIGEN RECOGNITION; APOPTOSIS; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL CYCLE G0 PHASE; CELL METABOLISM; CELL PROLIFERATION; CELL SIZE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE TARGETING; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HOMEOSTASIS; HUMAN; IMMUNOSTIMULATION; MULTIGENE FAMILY; PHENOTYPE; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION;

EID: 0038644122     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(03)00141-8     Document Type: Review

References (50)

1. Feske S., et al. Gene regulation mediated by calcium signals in T cells. Nat. Immunol. 2:2001;316-324.
2. Teague T.K., et al. Activation changes the spectrum but not the diversity of genes expressed by T cells. Proc. Natl. Acad. Sci. U. S. A. 96:1999;12691-12696.
3. Glynne R., et al. B-lymphocyte quiescence, tolerance and activation as viewed by global gene expression profiling on microarrays. Immunol. Rev. 176:2000;216-246.
4. Raaphorst F.M., et al. Polycomb-group genes as regulators of mammalian lymphopoiesis. Trends Immunol. 22:2001;682-690.
5. Turner J., Crossley M. Mammalian Kruppel-like transcription factors: more than just a pretty finger. Trends Biochem. Sci. 24:1999;236-240.
6. Schober S.L., et al. Expression of the transcription factor lung Kruppel-like factor is regulated by cytokines and correlates with survival of memory T cells in vitro and in vivo. J. Immunol. 163:1999;3662-3667.
7. Kuo C.T., et al. The LKLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryogenesis. Genes Dev. 11:1997;2996-3006.
8. Kuo C.T., et al. LKLF: A transcriptional regulator of single-positive T cell quiescence and survival. Science. 277:1997;1986-1990.
9. Buckley A.F., et al. Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc-dependent pathway. Nat. Immunol. 2:2001;698-704.
10. Levens D. Disentangling the MYC web. Proc. Natl. Acad. Sci. U. S. A. 99:2002;5757-5759.
11. Dang C.V. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol. 19:1999;1-11.
12. Bush A., et al. c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets. Genes Dev. 12:1998;3797-3802.
13. Grumont R.J., et al. B Cell growth is controlled by phosphatidylinosotol 3-kinase-dependent induction of Rel/NF-κB regulated c-myc transcription. Mol. Cell. 10:2002;1283-1294.
14. Coghill E., et al. Erythroid Kruppel-like factor (EKLF) coordinates erythroid cell proliferation and hemoglobinization in cell lines derived from EKLF null mice. Blood. 97:2001;1861-1868.
15. Chen X., et al. Kruppel-like factor 4 (gut-enriched Kruppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle. J. Biol. Chem. 276:2001;30423-30428.
16. Narla G., et al. KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science. 294:2001;2563-2566.
17. Fruman D.A., et al. Phosphoinositide 3-kinase and Bruton's tyrosine kinase regulate overlapping sets of genes in B cells. Proc. Natl. Acad. Sci. U. S. A. 99:2002;359-364.
18. Segre J.A., et al. Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat. Genet. 22:1999;356-360.
19. Tzachanis D., et al. Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells. Nat. Immunol. 2:2001;1174-1182.
20. Matsuda S., et al. In search of a function for the TIS21/PC3/BTG1/TOB family. FEBS Lett. 497:2001;67-72.
21. Yoshida Y., et al. Negative regulation of BMP/Smad signaling by Tob in osteoblasts. Cell. 103:2000;1085-1097.
22. Burgering B.M., Kops G.J. Cell cycle and death control: long live Forkheads. Trends Biochem. Sci. 27:2002;352-360.
23. Tran H., et al. The many forks in FOXO's road. Sci. STKE. 172:2003;RE5.
24. Vanhaesebroeck B., et al. Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70:2001;535-602.
25. Brunet A., et al. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr. Opin. Neurobiol. 11:2001;297-305.
26. Brunet A., et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 96:1999;857-868.
27. Medema R.H., et al. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature. 404:2000;782-787.
28. Dijkers P.F., et al. Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Mol. Cell. Biol. 20:2000;9138-9148.
29. Komatsu N., et al. A member of Forkhead transcription factor FKHRL1 is a downstream effector of STI571-induced cell cycle arrest in BCR-ABL-expressing cells. J. Biol. Chem. 278:2003;6411-6419.
30. Kops G.J., et al. Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol. Cell. Biol. 22:2002;2025-2036.
31. Stahl M., et al. The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. J. Immunol. 168:2002;5024-5031.
32. Fruman D.A., Cantley L.C. Phosphoinositide 3-kinase in immunological systems. Semin. Immunol. 14:2002;7-18.
33. Lam E.W., et al. Modulation of E2F activity in primary mouse B cells following stimulation via surface IgM and CD40 receptors. Eur. J. Immunol. 29:1999;3380-3389.
34. Kawamata H., et al. Induction of TSC-22 by treatment with a new anti-cancer drug, vesnarinone, in a human salivary gland cancer cell. Br. J. Cancer. 77:1998;71-78.
35. Shostak K.O., et al. Downregulation of putative tumor suppressor gene TSC-22 in human brain tumors. J. Surg. Oncol. 82:2003;57-64.
36. Shibanuma M., et al. Isolation of a gene encoding a putative leucine zipper structure that is induced by transforming growth factor β1 and other growth factors. J. Biol. Chem. 267:1992;10219-10224.
37. Becker W., Joost H.G. Structural and functional characteristics of Dyrk, a novel subfamily of protein kinases with dual specificity. Prog. Nucleic Acids Res. Mol. Biol. 62:1999;1-17.
38. von Groote-Bidlingmaier F., et al. DYRK1 is a co-activator of FKHR (FOXO1a)-dependent glucose-6-phosphatase gene expression. Biochem. Biophys. Res. Commun. 300:2003;764-769.
39. Tran H., et al. DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science. 296:2002;530-534.
40. Sheikh M.S., et al. Role of Gadd45 in apoptosis. Biochem. Pharmacol. 59:2000;43-45.
41. Ayroldi E., et al. Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor κB. Blood. 98:2001;743-753.
42. Mittelstadt P.R., Ashwell J.D. Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ. J. Biol. Chem. 276:2001;29603-29610.
43. D'Adamio, F. et al. (1997) A new dexamethasone-induced gene of the leucine zipper family protects T cells from TCR/CD3-activated cell death. Immunity 7, 803-812.
44. Frauwirth K.A., et al. The CD28 signaling pathway regulates glucose metabolism. Immunity. 16:2002;769-777.
45. Lee S.S. DAF-16 target genes that control C. elegans life-span and metabolism. Science. 300:2003;644-647.
46. - T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse. J. Immunol. 153:1994;3764-3774.
47. Bennett C.L., et al. A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA→AAUGAA) leads to the IPEX syndrome. Immunogenetics. 53:2001;435-439.
48. Hori S., et al. Control of regulatory T cell development by the transcription factor foxp3. Science. 299:2003;1057-1061.
49. Khattri R., et al. An essential role for Scurfin in CD4(+)CD25(+) T regulatory cells. Nat. Immunol. 4:2003;337-342.
50. Fontenot J.D., et al. Foxp3 programs the development and function of CD4(+)CD25(+) regulatory T cells. Nat. Immunol. 4:2003;330-336.